Even when a topic feels awkward to discuss, The Urology Group physicians encourage patients to be open and honest in order to get the best treatment.
In response to the COVID-19 health issue, we are offering telehealth as well as in-person appointments. Click to learn more.
A new study shows that cases of advanced prostate cancer in the United States are on the rise while cases of early stage prostate cancer are declining.
Researchers say the seemingly paradoxical figures are likely due to the changing landscape of screening and testing over the past 2 decades.
Dr. Gary Kirsh, president of The Urology Group was interviewed for this article.
Click here or the image to read full article.
Paradoxical figures between rise in advance prostate cancer cases and decline in early stage are likely due to the changing landscape of screening and testing over the past 2 decades.
Although it’s still the top cause of cancer-related deaths for men over 60, prostate cancer is a disease that can often be treated if detected early. CLICK TO READ FULL ARTICLE.